Business Description
Bioiasis AD
ISIN : BG1100008082
Description
Bioiasis AD provides specialized medical devices, equipment, and consultation services to state and private hospitals and trading companies. The company also deals in Interventional Cardiology and General Surgery consumables.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | 0.01 | |||||
| Debt-to-Equity | 116.02 | |||||
| Debt-to-EBITDA | 39.78 | |||||
| Interest Coverage | 0.19 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.84 | |||||
| Beneish M-Score | 11.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 20.6 | |||||
| 3-Year EPS without NRI Growth Rate | -109.7 | |||||
| 3-Year FCF Growth Rate | -418.2 | |||||
| 3-Year Book Growth Rate | -36.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.13 | |||||
| Quick Ratio | 1.13 | |||||
| Cash Ratio | 0.06 | |||||
| Days Sales Outstanding | 3376.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -33.71 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | 67.93 | |||||
| Net Margin % | -168.87 | |||||
| FCF Margin % | 241.98 | |||||
| ROE % | -153.25 | |||||
| ROA % | -2.31 | |||||
| ROIC % | 0.91 | |||||
| ROC (Joel Greenblatt) % | 9.13 | |||||
| ROCE % | 3.5 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 44033.21 | |||||
| PS Ratio | 88.84 | |||||
| PB Ratio | 157.65 | |||||
| Price-to-Tangible-Book | 160.8 | |||||
| Price-to-Free-Cash-Flow | 36.88 | |||||
| Price-to-Operating-Cash-Flow | 36.88 | |||||
| EV-to-EBIT | 93.2 | |||||
| EV-to-EBITDA | 93.2 | |||||
| EV-to-Revenue | 153.86 | |||||
| EV-to-FCF | 63.58 | |||||
| Earnings Yield (Greenblatt) % | 1.07 | |||||
| FCF Yield % | 2.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioiasis AD Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil лв) | 0.212 | ||
| EPS (TTM) (лв) | -0.31 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (лв) | 0 | ||
| 20-Day SMA (лв) | 16.08 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (лв) | 16.08 - 16.08 | ||
| Shares Outstanding (Mil) | 1.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioiasis AD Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioiasis AD Stock Events
| Event | Date | Price(лв) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bioiasis AD Frequently Asked Questions
What is Bioiasis AD(XBUL:BIOA)'s stock price today?
The current price of XBUL:BIOA is лв16.08. The 52 week high of XBUL:BIOA is лв16.08 and 52 week low is лв16.08.
When is next earnings date of Bioiasis AD(XBUL:BIOA)?
The next earnings date of Bioiasis AD(XBUL:BIOA) is .
Does Bioiasis AD(XBUL:BIOA) pay dividends? If so, how much?
Bioiasis AD(XBUL:BIOA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers